2026 Pediatric Rheumatology Symposium

March 18-21, 2026. Minneapolis, MN.

View by Number View by Title View Sessions

Thursday, March 19, 2026

6:00PM-7:00PM: Abstract Number: 031

Clinical Characteristics and Diagnostic Predictors of Inflammatory Bowel Disease in Patients with Chronic Nonbacterial Osteomyelitis – A Single Center Retrospective Analysis

Posters: Clinical and Therapeutic Aspects I

6:00PM-7:00PM: Abstract Number: 048

Clinical characteristics of childhood-onset primary Sjögren’s syndrome in South Korea: two centers’ experiences

Posters: Clinical and Therapeutic Aspects I

6:00PM-7:00PM: Abstract Number: 078

Development of A High-Parameter Whole Blood Thrombo-inflammation Flow Cytometry Panel for Research in Pediatric Autoimmune Diseases

Posters: Genetics and Pathogenesis I

6:00PM-7:00PM: Abstract Number: 051

Do Changes in the Weather Influence Joint Pain and Stiffness in Children with Juvenile Idiopathic Arthritis?

Posters: Clinical and Therapeutic Aspects I

6:00PM-7:00PM: Abstract Number: 044

Efficacy of Rituximab Biosimilars in Pediatric ANCA-Associated Vasculitis

Posters: Clinical and Therapeutic Aspects I

6:00PM-7:00PM: Abstract Number: 070

Empowering Voices: Inception of a Parent Led Anatomical Visual Pain Assessment Tool for Juvenile Arthritis

Posters: Special Category: Patient Engagement

6:00PM-7:00PM: Abstract Number: 062

Evaluating the Relationship Between an Electronic Transition Planning Tool and Transition Success in a Pediatric Rheumatology Clinic

Posters: Quality, Health Services, and Education Research I

6:00PM-7:00PM: Abstract Number: 009

Functional Lumen Imaging Probe (FLIP) for the Assessment of Esophageal Involvement in Juvenile Systemic Sclerosis: Characteristics and Clinical Utility

Posters: Clinical and Therapeutic Aspects I

6:00PM-7:00PM: Abstract Number: 045

Genotypes and Clinical Phenotypes of Monogenic Autoinflammatory Disorders in Michigan

Posters: Clinical and Therapeutic Aspects I

6:00PM-7:00PM: Abstract Number: 036

Giant Aneurysms in Kawasaki Disease: A Large Quarternary Single Center Experience

Posters: Clinical and Therapeutic Aspects I

6:00PM-7:00PM: Abstract Number: 068

Identification of Challenges in the Quality of Referrals to a Pediatric Rheumatology Center: A Retrospective Chart Review

Posters: Quality, Health Services, and Education Research I

6:00PM-7:00PM: Abstract Number: 060

Impact of Social Determinants of Health on Outcomes in Pediatric Uveitis

Posters: Quality, Health Services, and Education Research I

6:00PM-7:00PM: Abstract Number: 061

Impacts of Social Drivers of Health on Outcomes for Patients with Pediatric Systemic Lupus Erythematosus

Posters: Quality, Health Services, and Education Research I

6:00PM-7:00PM: Abstract Number: 063

Improving Pediatric Lupus Patient Education: Patient and Provider Needs Assessment

Posters: Quality, Health Services, and Education Research I

6:00PM-7:00PM: Abstract Number: 066

Incidence of Juvenile Idiopathic Arthritis in Chile: Estimates from a National Universal Access Program, 2010-2024

Posters: Quality, Health Services, and Education Research I

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].